Laminopathie Joint laxity Adult SMA Mutations Muscle Laminopathies Regeneration COL6A1 Maladies rares Myopathies Clinical trial CRISPR Errance diagnostique A-type lamin Cardiomyopathy RNA interference Emery-Dreifuss muscular dystrophy LGMD CSF protein C2C12 A-type lamins Myogenesis Skeletal muscle Therapy Acetyltransferase Dilated cardiomyopathy Lamins Heart failure Emerin Cancer INPP5K Actionability Cardiology Cardiac conduction system Angiotensin-converting enzyme inhibitor Duchenne muscular dystrophy Becker muscular dystrophy Alternative splicing Biomarker C elegans Butyrylcholinesterase Rare diseases Myotubes Myopathy Angiotensin-converting enzyme inhibitors Lamin A/C Calcium handling AAV VECTOR COVID-19 Muscle biopsy Patient registry AAV Base de données FAIR Neuromuscular diseases Allele-specific silencing therapy Laminopathy Connective tissue Exome Congenital muscular dystrophy Muscular dystrophy MD LMNA-related congenital muscular dystrophy LMNA Hypermobile EDS Lamin A/C nuclei Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophine Diagnosis BVES Centronuclear myopathy Muscle MRI Nuclear envelope Allele‐specific silencing therapy Dynamin 2 Next generation sequencing Biological sciences Heart Ehlers‐Danlos Syndrome Gene therapy Actionable gene Lamin A/C LMNA gene Titin Allele-specific silencing COL1A1 Dystrophie musculaire Mouse Rare neuromuscular diseases BiP Treatment Treatment delay COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders LMNA gene Muscular dystrophy POPDC1 CMTX Maladies rares et orphelines Autophagosome maturation GNE IPSC Cancer biomarkers Myologie